---
title: "ALTAMIRA THERAPEUTICS LTD (CYTOF.US) — 财务报表"
type: "Symbol"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/quote/CYTOF.US/norm.md"
symbol: "CYTOF.US"
name: "ALTAMIRA THERAPEUTICS LTD"
parent: "https://longbridge.com/zh-CN/quote/CYTOF.US.md"
datetime: "2026-05-20T18:12:46.000Z"
locales:
  - [en](https://longbridge.com/en/quote/CYTOF.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/CYTOF.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/CYTOF.US/norm.md)
---

# ALTAMIRA THERAPEUTICS LTD (CYTOF.US) — 财务报表

## 利润表 (USD)

| 指标 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
| --- | --- | --- | --- | --- | --- |
| 每股收益 | -0.1530 | -0.1530 | -0.5713 | -0.5713 | -1.05 |
| ROE | -75.36% | -57.71% | -125.45% | -127.85% | -137.37% |
| 营业收入 | - | - | - | - | - |
| 净利润 | -767506.00 | -767506.00 | -2.06M | -2.06M | -2.17M |
| 营业利润 | -1.31M | -1.31M | -1.47M | -1.47M | -1.96M |
| 毛利率 | - | - | - | - | - |
| 净利率 | - | - | - | - | - |
| 利润含金量 | - | - | - | - | - |

## 资产负债表 (USD)

| 指标 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
| --- | --- | --- | --- | --- | --- |
| 资产与负债 | 7.13M | 7.13M | 8.65M | 8.65M | 8.07M |
| 权益乘数 | 1.75 | 1.75 | 1.32 | 1.32 | 1.28 |
| 每股净资产 | 0.7128 | 0.7128 | 1.41 | 1.41 | 2.37 |
| 资产周转率 | - | - | - | - | - |
| 现金及短投 | 3755.00 | 3755.00 | 998624.00 | 998624.00 | 65455.00 |
| 存货与应收 | - | - | - | - | - |
| 长期投资 | 430707.00 | 430707.00 | 449905.00 | 449905.00 | 417620.00 |
| 净债务 | 786294.00 | 786294.00 | -637571.00 | -637571.00 | 361982.00 |

## 现金流量表 (USD)

| 指标 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
| --- | --- | --- | --- | --- | --- |
| 经营现金流 | -692067.00 | -692067.00 | -1.45M | -1.45M | -1.60M |
| 投资现金流 | -231.00 | -231.00 | -57982.00 | -57982.00 | 310.00 |
| 融资现金流 | 183969.00 | 183969.00 | 2.00M | 2.00M | 1.26M |
| 自由现金流 | -652045.00 | 322303.00 | -796298.00 | -942174.00 | -1.07M |
| 现金流充裕率 | -2191.75% | -2191.75% | -1732.82% | -1732.82% | -4393.18% |
| 举债与偿债 | 219204.00 | 219204.00 | - | - | - |
| 资本支出 | - | - | -51544.00 | -51544.00 | - |